Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela is recurrent gastrointestinal (GI) bleeding. Bevacizumab (Bev) is emerging as an effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Masood, Muaaz, Coles, Michael, Sifuentes, Humberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263270/
https://www.ncbi.nlm.nih.gov/pubmed/34306771
http://dx.doi.org/10.1155/2021/2242178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263270/
https://www.ncbi.nlm.nih.gov/pubmed/34306771
http://dx.doi.org/10.1155/2021/2242178

Ejemplares similares